Ernexa Therapeutics Inc. (ERNA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.84M
Last updated: Nov 17, 2026 at 11:04 AM ET
Ernexa Therapeutics Inc. (ERNA) Stock Forecast
Analysts expect Ernexa Therapeutics (ERNA) to earn -$18.02 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$1.86.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$18.02
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$1.86
- EPS consensus
- Next report
- Mar 11, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$18.02 | -$18.02 to -$18.02 | 1 |
| Dec 31, 2027 | -$1.86 | -$1.86 to -$1.86 | 1 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 0 upward and 2 downward EPS revisions. Cuts outnumber raises in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 0 | 1 |
| Fiscal year ending Dec 31, 2027 | 0 | 1 |
EPS Trend
The EPS consensus for the fiscal year ending Dec 31, 2026 has held over the last 60 days.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$18.02 | -$18.02 | -$18.02 | -$18.02 | N/A | N/A |
| Fiscal year ending Dec 31, 2027 | -$1.86 | -$1.86 | -$1.86 | -$1.86 | N/A | N/A |
Frequently Asked Questions About ERNA
What is the ERNA stock forecast?
Consensus analyst estimates put Ernexa Therapeutics's EPS at -$18.02 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from ERNA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$18.02, with estimates from -$18.02 to -$18.02 from 1 analyst. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$1.86, with estimates from -$1.86 to -$1.86 from 1 analyst.
How many analysts cover ERNA?
1 analyst estimates EPS for Ernexa Therapeutics for the fiscal year ending Dec 31, 2026.
ERNA pages: Overview, Earnings, Forecast, Financials, Competitors